• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications.评估人类多能干细胞及其衍生物用于临床应用的安全性。
Stem Cell Reports. 2017 Jul 11;9(1):1-4. doi: 10.1016/j.stemcr.2017.05.029.
2
The safety of human pluripotent stem cells in clinical treatment.人类多能干细胞在临床治疗中的安全性。
Ann Med. 2015;47(5):370-80. doi: 10.3109/07853890.2015.1051579. Epub 2015 Jul 6.
3
Understanding Melanocyte Stem Cells for Disease Modeling and Regenerative Medicine Applications.用于疾病建模和再生医学应用的黑素细胞干细胞研究
Int J Mol Sci. 2015 Dec 21;16(12):30458-69. doi: 10.3390/ijms161226207.
4
Virus-free pluripotency for human cells.人类细胞的无病毒多能性
Nature. 2009 Mar 5;458(7234):19. doi: 10.1038/458019a.
5
Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation.人类多能干细胞分化中的氧化还原与表观遗传学
Antioxid Redox Signal. 2021 Feb 1;34(4):335-349. doi: 10.1089/ars.2019.7983. Epub 2020 Jul 17.
6
The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells.重编程方法和多能性状态在患者特异性人多能干细胞向配子分化中的作用。
Mol Hum Reprod. 2018 Apr 1;24(4):173-184. doi: 10.1093/molehr/gay007.
7
Clinical potentials of human pluripotent stem cells.人类多能干细胞的临床潜力。
Cell Biol Toxicol. 2017 Aug;33(4):351-360. doi: 10.1007/s10565-017-9384-y. Epub 2017 Feb 8.
8
Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.再生医学与药物研发中来自人类多能干细胞的心肌细胞。
Trends Pharmacol Sci. 2009 Oct;30(10):536-45. doi: 10.1016/j.tips.2009.07.001. Epub 2009 Sep 15.
9
A call to action for deciphering genetic variants in human pluripotent stem cells for cell therapy.
Cell Stem Cell. 2025 Apr 3;32(4):508-512. doi: 10.1016/j.stem.2025.03.003.
10
Reprogrammed cells for disease modeling and regenerative medicine.用于疾病建模和再生医学的重编程细胞。
Annu Rev Med. 2013;64:277-90. doi: 10.1146/annurev-med-050311-163324.

引用本文的文献

1
3D Printing for Neural Repair: Bridging the Gap in Regenerative Medicine.用于神经修复的3D打印:弥合再生医学的差距。
Adv Mater. 2025 Sep;37(36):e07590. doi: 10.1002/adma.202507590. Epub 2025 Jul 30.
2
Chromosomal quality control in hPSCs: A practical guide to SNP array analysis with GenomeStudio.人多能干细胞中的染色体质量控制:使用GenomeStudio进行SNP阵列分析的实用指南。
Front Cell Dev Biol. 2025 Jul 1;13:1599923. doi: 10.3389/fcell.2025.1599923. eCollection 2025.
3
Selective Elimination of Genetic Variants of Human Embryonic Stem Cells from High Vulnerability to Ferroptosis.从对铁死亡高易感性中选择性消除人类胚胎干细胞的遗传变异体
Biomater Res. 2024 Oct 25;28:0093. doi: 10.34133/bmr.0093. eCollection 2024.
4
Optimized Prime Editing of Human Induced Pluripotent Stem Cells to Efficiently Generate Isogenic Models of Mendelian Diseases.优化人类诱导多能干细胞的碱基编辑以有效生成孟德尔疾病的同基因模型。
Int J Mol Sci. 2024 Dec 26;26(1):114. doi: 10.3390/ijms26010114.
5
Longitudinal analysis of genetic and epigenetic changes in human pluripotent stem cells in the landscape of culture-induced abnormality.在培养诱导异常背景下对人类多能干细胞中基因和表观遗传变化的纵向分析。
Exp Mol Med. 2024 Nov;56(11):2409-2422. doi: 10.1038/s12276-024-01334-8. Epub 2024 Nov 1.
6
Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases.将线粒体生物学融入神经退行性疾病的创新细胞疗法
Brain Sci. 2024 Sep 5;14(9):899. doi: 10.3390/brainsci14090899.
7
De Novo Cancer Mutations Frequently Associate with Recurrent Chromosomal Abnormalities during Long-Term Human Pluripotent Stem Cell Culture.长期人多能干细胞培养过程中,新生癌症突变常与复发性染色体异常相关。
Cells. 2024 Aug 21;13(16):1395. doi: 10.3390/cells13161395.
8
Germ cell tumors, cell surface markers, and the early search for human pluripotent stem cells.生殖细胞肿瘤、细胞表面标志物与人类多能干细胞的早期寻找。
Bioessays. 2024 Dec;46(12):e2400094. doi: 10.1002/bies.202400094. Epub 2024 Aug 8.
9
Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q.无饲养层培养的人类多能干细胞驱动 MDM4 介导的 1q 染色体获得。
Stem Cell Reports. 2024 Aug 13;19(8):1217-1232. doi: 10.1016/j.stemcr.2024.06.003. Epub 2024 Jul 3.
10
Unlocking the Future: Pluripotent Stem Cell-Based Lung Repair.解锁未来:基于多能干细胞的肺修复。
Cells. 2024 Apr 5;13(7):635. doi: 10.3390/cells13070635.

本文引用的文献

1
Large-Scale Analysis of Loss of Imprinting in Human Pluripotent Stem Cells.人类多能干细胞印记丢失的大规模分析
Cell Rep. 2017 May 2;19(5):957-968. doi: 10.1016/j.celrep.2017.04.020.
2
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations.人类多能干细胞经常获得并扩增显性负性P53突变。
Nature. 2017 May 11;545(7653):229-233. doi: 10.1038/nature22312. Epub 2017 Apr 26.
3
Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.自体诱导干细胞衍生的视网膜细胞治疗黄斑变性。
N Engl J Med. 2017 Mar 16;376(11):1038-1046. doi: 10.1056/NEJMoa1608368.
4
Spontaneous Single-Copy Loss of TP53 in Human Embryonic Stem Cells Markedly Increases Cell Proliferation and Survival.人类胚胎干细胞中TP53的自发单拷贝缺失显著增加细胞增殖和存活。
Stem Cells. 2017 Apr;35(4):872-885. doi: 10.1002/stem.2550. Epub 2017 Jan 19.
5
Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells.检测人类多能干细胞培养中的基因嵌合现象。
Stem Cell Reports. 2016 Nov 8;7(5):998-1012. doi: 10.1016/j.stemcr.2016.10.003.
6
Mutational History of a Human Cell Lineage from Somatic to Induced Pluripotent Stem Cells.从体细胞到诱导多能干细胞的人类细胞谱系的突变史
PLoS Genet. 2016 Apr 7;12(4):e1005932. doi: 10.1371/journal.pgen.1005932. eCollection 2016 Apr.
7
Pluripotent stem cells progressing to the clinic.多能干细胞向临床应用推进。
Nat Rev Mol Cell Biol. 2016 Mar;17(3):194-200. doi: 10.1038/nrm.2016.10.
8
Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients.使用胚胎干细胞衍生的视网膜色素上皮细胞治疗黄斑变性:亚洲患者的初步结果。
Stem Cell Reports. 2015 May 12;4(5):860-72. doi: 10.1016/j.stemcr.2015.04.005. Epub 2015 Apr 30.
9
Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.人胚胎干细胞源性视网膜色素上皮细胞治疗年龄相关性黄斑变性和斯塔加特型黄斑营养不良患者:两项开放性、1/2 期研究的随访。
Lancet. 2015 Feb 7;385(9967):509-16. doi: 10.1016/S0140-6736(14)61376-3. Epub 2014 Oct 15.
10
Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells.非整倍体诱导人类多能干细胞的基因表达、增殖和致瘤性发生深刻变化。
Nat Commun. 2014 Sep 8;5:4825. doi: 10.1038/ncomms5825.

评估人类多能干细胞及其衍生物用于临床应用的安全性。

Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications.

机构信息

Department of Biomedical Science, Centre for Stem Cell Biology, University of Sheffield, Sheffield S10 2TN, UK.

The Broad Institute, Cambridge, MA 02142, USA.

出版信息

Stem Cell Reports. 2017 Jul 11;9(1):1-4. doi: 10.1016/j.stemcr.2017.05.029.

DOI:10.1016/j.stemcr.2017.05.029
PMID:28700896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7206225/
Abstract

Pluripotent stem cells may acquire genetic and epigenetic variants during culture following their derivation. At a conference organized by the International Stem Cell Initiative, and held at The Jackson Laboratory, Bar Harbor, Maine, October 2016, participants discussed how the appearance of such variants can be monitored and minimized and, crucially, how their significance for the safety of therapeutic applications of these cells can be assessed. A strong recommendation from the meeting was that an international advisory group should be set up to review the genetic and epigenetic changes observed in human pluripotent stem cell lines and establish a framework for evaluating the risks that they may pose for clinical use.

摘要

多能干细胞在其衍生后的培养过程中可能会获得遗传和表观遗传变异。2016 年 10 月,在缅因州巴港的杰克逊实验室举行的国际干细胞倡议组织的会议上,与会者讨论了如何监测和尽量减少此类变异的出现,以及如何评估它们对这些细胞治疗应用安全性的意义。会议强烈建议成立一个国际顾问小组,以审查在人类多能干细胞系中观察到的遗传和表观遗传变化,并建立一个评估它们对临床应用可能构成的风险的框架。